Get startedLog in
    Picture of Nanoform Finland Oyj logo

    NANOFH — Nanoform Finland Oyj News Story

    0.000.00%
    fi flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Nanoform Finland Starts Pivotal Bioequivalence Studies Of Nanoenzalutamide

    Picture of Nanoform Finland Oyj logoNanoform Finland Oyj
    12/06/2025 06:18
    June 12 (Reuters) - Nanoform Finland Oyj NANOFH.HE:

STARTS PIVOTAL BIOEQUIVALENCE STUDIES OF NANOENZALUTAMIDE

FIRST LICENSE AND SUPPLY AGREEMENT SIGNED IN GERMANY

Source text: ID:nMFNjVxjh

Further company coverage: NANOFH.HE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))

    Recent news on Nanoform Finland Oyj

    See all news